BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1026810)

  • 1. Side effects of clofazimine therapy.
    Ramu G; Iyer GG
    Lepr India; 1976 Oct; 48(4 Suppl):722-31. PubMed ID: 1026810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 3. Limitations of clofazimine in the treatment of lepra reactions.
    Mishra B; Girdhar BK
    Indian J Lepr; 1986; 58(1):73-8. PubMed ID: 3746000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation from lepromatous to borderline leprosy under clofazimine therapy.
    Mahapatra SB; Ramu G
    Lepr India; 1976 Apr; 48(2):172-6. PubMed ID: 1022964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine.
    Ramu G; Girdhar A
    Lepr India; 1979 Oct; 51(4):497-504. PubMed ID: 522443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofazimine in lepra (ENL) reaction, one year clinical trial.
    Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
    Lepr India; 1983 Apr; 55(2):265-77. PubMed ID: 6355652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of three-year multidrug therapy in multibacillary leprosy patients.
    Li W; Ye G; Yang Z; Tao M; Luo J; Wang C; Ji F
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):37-40. PubMed ID: 2371263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative evaluation of levamisole in leprosy.
    Sharma L; Thalliath GH; Girgia HS; Sen PC
    Indian J Lepr; 1985; 57(1):11-6. PubMed ID: 3839808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple drug therapy--a comparative study with 2 tier and 3 tier combination of rifampicin, clofazimine, DDS, INAH and thiacetazone in lepromatous cases.
    Kundu SK; Ghosh S; Hazra S; Chaudhury S
    Lepr India; 1981 Apr; 53(2):248-58. PubMed ID: 6166791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial with clofazimine in leprosy.
    Ganapati R; Dongre VV
    Lepr India; 1976 Oct; 48(4 Suppl):703-8. PubMed ID: 1026807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 13. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More about clofazimine--3 years experience and review of literature.
    Kumar B; Kaur S; Kaur I; Gangowar DN
    Indian J Lepr; 1987; 59(1):63-74. PubMed ID: 3611862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of clofazimine on liver function tests in lepra reaction (ENL).
    Bulakh PM; Kowale CN; Ranade SM; Burte NP; Chandorkar AG
    Lepr India; 1983 Oct; 55(4):714-8. PubMed ID: 6668931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin A levels of ichthyotic and non-ichthyotic skin and plasma of leprosy patients with and without clofazimine therapy.
    Bharadwaj VP; Sritharan V; Venkatesan K; Girdhar A; Ramu G
    Indian J Med Res; 1982 Jun; 75():773-7. PubMed ID: 7129548
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.